Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CXCR6 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | AQP9 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | IFT88 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | UBXN10 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | SERPINA1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | KIR2DL4 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | HAVCR2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | GK | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | MRPS10 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |